FOLH1 and posterior cortical atrophy: Recently, PSMA-PET/CT has been endorsed by the EAU, the European Society for Medical Oncology (ESMO), and the Chinese Urological Association as a vital method for early diagnosis and for evaluating PCa recurrence and metastasis (52).